ViQi develops custom, AI-powered image solutions and bioassays tailored to specific scientific requirements. These solutions integrate seamlessly into existing workflows, accelerating drug development and reducing associated costs. The company focuses on delivering precise, compliance-driven innovation to help clients bring advanced therapies to market faster.
Funding
$1.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional bioassays in health, life, and earth sciences often suffer from inefficiencies, high costs, and time-consuming processes, hindering the pace of research and drug development. Existing off-the-shelf solutions may not adequately address specific scientific needs, requiring customized approaches.
Solution
ViQi provides custom, AI-powered image analysis assays tailored to the unique requirements of health, life, and earth science research. The platform optimizes bioassays by integrating seamlessly into existing workflows, reducing both time and costs associated with traditional methods. By leveraging artificial intelligence, ViQi enables scientists to uncover insights faster and accelerate the development of advanced therapies. The company's cross-disciplinary team delivers solutions designed for regulatory compliance and operational efficiency.
Target Audience
ViQi's primary customers are researchers and scientists in health, life, and earth sciences seeking to optimize bioassays and accelerate drug development.
Features
- Custom-built, AI-driven assays tailored to specific scientific needs
- End-to-end integration with existing workflows
- AI-powered image solutions that bridge life sciences, computer science, and imaging
- Solutions designed with regulatory compliance in mind
- Ability to reduce time and costs associated with traditional drug development and bioassay processes